1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47296
Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117
Email jamie-miller@ouhsc.edu
Publications & Presentations
- 36. Lim S Y, May C B, Johnson P N, Miller J L. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatric research. 2022
37. Taher K W, Johnson P N, Miller J L, Neely S, Gupta N. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Frontiers in pediatrics. 2022; 10 : 860921
38. Bobo K S, Cober M P, Eiland L S, Heigham M, King M, Johnson P N, Miller J L, Sierra C M. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2022; 79 : 823
39. Amber T, Nguyen P B, Miller J L, Neely S, Lewis T V. Incidence of Cytomegalovirus DNAemia in Pediatric Post-Renal Transplant Patients Receiving Weight-Based vs Body Surface Area-Based Valganciclovir Chemoprophylaxis . The Journal of Pediatric Pharmacology and Therapeutics. 2022; 27 : 164-171
40. Miller J L, Oldham M M, Neely S, Medina M. Impact of Transitioning a Senior Seminar Capstone Course from Weekly Classes to an Intensive Hybrid Course. American journal of pharmaceutical education. 2022
Grants
- 1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.
2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
Awards and Honors
- 1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2024.
3. American Society of Health-System Pharmacists. Fellow of American Society of Health-System Pharmacists. Date: 2024.
4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
5. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.
Education
- 1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.
2. Degree: BS. Trevecca Nazarene University. Date: 2002.